Goldman Sachs’s Bioceres Crop Solutions BIOX Stock Holding History

Goldman Sachs’s Portfolio BIOX Stock Details BIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$52K	Buy	116,875 +9,234	+9%	+$7.01K	﹤0.01%	6294
2025 Q4	$141K	Buy	107,641 +81,924	+319%	+$131K	﹤0.01%	6128
2025 Q3	$36.3K	Buy	+25,717	New	+$78.4K	﹤0.01%	6203
2025 Q1	–	Sell	-12,012	Closed	-$73K	–	6069
2024 Q4	$73K	Sell	12,012 -5,860	-33%	-$40K	﹤0.01%	5812
2024 Q3	$141K	Buy	17,872 +4,211	+31%	+$42.5K	﹤0.01%	5530
2024 Q2	$153K	Sell	13,661 -7,749	-36%	-$90.6K	﹤0.01%	5328
2024 Q1	$271K	Buy	+21,410	New	+$282K	﹤0.01%	5015
2023 Q4	–	Sell	-15,532	Closed	-$175K	–	5628
2023 Q3	$175K	Buy	15,532 +2,388	+18%	+$28.6K	﹤0.01%	5071
2023 Q2	$176K	Buy	+13,144	New	+$154K	﹤0.01%	5225

Other funds holding BIOX

Solel Partners Boston, Massachusetts $468M AUM 2.45% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs's BIOX Position: Q1 2026 in Review

Goldman Sachs increased its Bioceres Crop Solutions (BIOX) stake by 8.6% in Q1 2026, buying an estimated $7.01K and bringing the position to 116,875 shares worth $52K. The position accounts for ﹤0.01% of the portfolio, ranked #6294.

Goldman Sachs first reported a position in BIOX in Q2 2023 and has held it in 9 quarters since. The position peaked at $271K in Q1 2024. 32 funds tracked by Wall St. Rank hold BIOX as of Q1 2026.

Goldman Sachs held 116,875 shares of Bioceres Crop Solutions worth $52K as of Q1 2026.
Goldman Sachs bought 9,234 Bioceres Crop Solutions shares in Q1 2026, an estimated $7.01K.
Bioceres Crop Solutions made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6294 holding.
Goldman Sachs first reported a position in Bioceres Crop Solutions in Q2 2023 and has held it in 9 quarters since.
Goldman Sachs's Bioceres Crop Solutions position peaked at $271K in Q1 2024.
32 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.